<?xml version="1.0" encoding="UTF-8"?>
<p id="p0215">SARS in semen investigation into the effect of novel coronaviruses on fertility began after the discovery that angiotensin-converting enzyme 2 (ACE-2), which is expressed in the testis, acts as a functional receptor for the SARS virus.
 <xref rid="bib88" ref-type="bibr">
  <sup>88</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib89" ref-type="bibr">
  <sup>89</sup>
 </xref> Zhao et al
 <xref rid="bib90" ref-type="bibr">
  <sup>90</sup>
 </xref> first reported detection of the virus within testicular epithelial cells and Leydig cells through combined ISH and TEM. However, no other research teams have been able to mirror these results.
 <xref rid="bib91" ref-type="bibr">91</xref>, 
 <xref rid="bib92" ref-type="bibr">92</xref>, 
 <xref rid="bib93" ref-type="bibr">93</xref> Ding et al
 <xref rid="bib91" ref-type="bibr">
  <sup>91</sup>
 </xref> examined all tissues that express ACE-2 in 4 autopsies of patients with SARS and were surprised to find that the testes were uniformly negative for the SARS RNA and signature N protein despite high levels of ACE-2 expression in the testes. Similarly, Gu et al
 <xref rid="bib92" ref-type="bibr">
  <sup>92</sup>
 </xref> noted focal testicular atrophy in all 8 autopsies with confirmed SARS but found no evidence of SARS in parenchymal tissue by ISH and TEM. Therefore, although semen has not been directly examined for SARS, indirect evidence suggests that it is unlikely to be a reservoir.
</p>
